Anti-osteoporotic therapy in Denmark—predictors and demographics of poor refill compliance and poor persistence-Reference-Cited by-同舟云学术

Anti-osteoporotic therapy in Denmark—predictors and demographics of poor refill compliance and poor persistence

Published:2012-11-22 Issue:7 Volume:24 Page:2079-2097
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Hansen C.,Pedersen B. D.,Konradsen H.,Abrahamsen B.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-012-2221-5.pdf

Reference34 articles.

1. Cadarette SM, Burden AM (2010) Measuring and improving adherence to osteoporosis pharmacotherapy. Curr Opin Rheumatol 22(4):397–403. doi: 10.1097/BOR.0b013e32833ac7fe

2. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10(4):259–264. doi: 10.1007/s001980050224

3. Sundhedsstyrelsen. Sund hele livet—de nationale mål og strategier for folkesundheden 2002–10. http://www.folkesundhed.dk/media/sundhelelivet.pdf . 2008

4. WHO. The World Health Report. http://www.who.int/whr/2008/en/index.html . 2008

5. Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38(2 Suppl 1):S4–S9. doi: 10.1016/j.bone.2005.11.024

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing Healthcare Disparities and Improving Osteoporosis Management in Rural Communities: A Randomized Control Trial (Preprint);2024-03-18

2. The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare;Bone;2024-01

3. Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study;Endocrinology and Metabolism;2023-04-30

4. Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment in Denmark: a population-based cohort study;Archives of Osteoporosis;2023-01-11

5. Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms;Therapeutic Advances in Chronic Disease;2022-01